Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

Clinical trial NCT04674683 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04674683
Sponsor: HUYABIO International, LLC.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Unresectable or Metastatic Melanoma Progressive Brain Metastasis

Start date: 2021-08-12
Primary completion: 2026-07-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.